TTY Biopharm To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.
· Issued by Tty Biopharm Company Limited
Close
Today's Information
Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO
2
Date of announcement
2022/05/26
Time of announcement
17:03:34
Subject
To announce the Company received milestone from
global pharmaceutical company for co-development
overseas market of long-lasting microsphere drug.
Date of events
2022/05/26
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/05/26
2.Company name:TTY Biopharm Company
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):Head office
4.Reciprocal shareholding ratios:Not applicable
5.Cause of occurrence:
The Company received milestone for USD 500,000 from global pharmaceutical
company for co-development overseas market of long-lasting microsphere drug,
"Octreotide LAR" due to the Company has completed pilot clinical trial.
6.Countermeasures:To announce major information
7.Any other matters that need to be specified:None.
